Revenue: The sum of all revenue fields included for a company's operating activities.
Gilead Sciences, Inc. (GILD) had Revenue of $6.96B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$6.96B |
$2.02B |
|
$1.45B |
|
$5.51B |
|
$4.38B |
|
$2.58B |
|
$-5.00M |
|
$2.58B |
|
$2.58B |
|
$2.02B |
|
$2.02B |
|
$2.02B |
|
$2.02B |
|
$2.58B |
|
$3.27B |
|
1.24B |
|
1.25B |
|
$1.63 |
|
$1.61 |
|
| Balance Sheet Financials | |
$18.64B |
|
$5.64B |
|
$37.64B |
|
$56.28B |
|
$9.48B |
|
$20.86B |
|
$23.37B |
|
$32.85B |
|
$23.43B |
|
$-1.26B |
|
$23.43B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$2.54B |
|
$1.77B |
|
$-4.24B |
|
$7.56B |
|
$7.63B |
|
$65.00M |
|
$218.00M |
|
$-1.04B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.97 |
|
-- |
|
-- |
|
0.47 |
|
0.95 |
|
79.24% |
|
37.14% |
|
37.14% |
|
-- |
|
37.07% |
|
29.04% |
|
$2.43B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.76 |
|
1.47 |
|
61.31 |
|
8.63% |
|
-159.76% |
|
3.59% |
|
4.56% |
|
$18.87 |
|
$1.94 |
|
$2.03 |
|